Results 191 to 200 of about 258,864 (309)

From quality indicator to quality measurement: design and implementation of an automated audit and feedback tool for chronic kidney disease in Belgian primary care. [PDF]

BMJ Health Care Inform
Soetaert J, Paredis L, Vaes B, Van den Wyngaert I, Van Pottelbergh G, Van den Bulck S.   +5 more
europepmc   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Association Between Chronic Kidney Disease and Incident Ménière's Disease Using 16 Years of Nationwide Longitudinal Data. [PDF]

J Clin Med
Kim ES, Kim JK, Kim H, Lee JS, Kang JW, Kim MJ, Kang HS, Yoo DM, Han KM, Kim NY, Choi HG, Kwon MJ.   +11 more
europepmc   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Cognitive Impairment Across the Spectrum of Chronic Kidney Disease: Clinical Characteristics and Implications for Practice-Is There a Role for Medical Nutritional Therapy? [PDF]

Nutrients
Neicu M, Verzan C, Dusa A, Stepan E, Iorga CIM, Beldea G, Simtea S, Garneata L.   +7 more
europepmc   +1 more source

Iranian Chronic Kidney Disease Biobank as a comprehensive resource for next-generation research: study design and protocol. [PDF]

BMJ Open
Gholaminejad A, Maleki S, Ziaei O, Eatesami H, Gheisari Y, Ramazani Z, Toghyani A, Mortazavi M.   +7 more
europepmc   +1 more source

The Impact of Ultra-Processed Foods on Chronic Kidney Disease Progression. [PDF]

Nutrients
Młynarska E, Hossa K, Kłosowicz A, Krupińska N, Kuzar P, Majtas A, Możdżan Z, Prusak A, Szymańska P, Wieczorek A, Rysz J, Franczyk B.   +11 more
europepmc   +1 more source

Comprehensive trends in Chronic Kidney Disease prevalence and comorbidities across eGFR and albuminuria categories: a 20-year analysis of NHANES data. [PDF]

Ren Fail
Farag YM, Zheng Z, Dar AH, Tariq A.
europepmc   +1 more source

Editorial: Biomarkers in CKD [PDF]

Frontiers in Medicine, 2017
Magali Araujo, Sonia Q. Doi
openaire   +3 more sources

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

FlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu, Yubing Hu, Dong Wang, Ben Zhong Tang   +3 more
wiley   +1 more source